Abiopharma

🔍 Tapiero Jacques (Director)

Company: MCCORMICK & CO INC (MKC)

Report Date: 2026-07-20

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock - Voting (Direct)
  Date: 2026-07-20 | Code: H | shares_owned_after: 33,818.05
• Holds 0 shares of Common Stock - Non Voting (Direct)
  Date: 2026-07-20 | Code: H | shares_owned_after: 2,620.00
• Acquired 24 shares of Phantom Stock (Derivative)
  Date: 2026-07-20 | Code: J | equity_swap_involved: 0 | shares_owned_after: 2,629.52 | transaction_form_type: 5 | Footnotes: F1, F1, F1
• Acquired 186 shares of Phantom Stock (Derivative)
  Date: 2026-09-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,815.40 | transaction_form_type: 4 | Footnotes: F2, F2, F2

Footnotes:

• F1: Dividend Reinvestment
• F2: Each share of phantom stock represents the right to receive one share of Common Stock - Voting. Shares of Phantom Stock are payable in shares of Common Stock - Voting in accordance with the terms of the Non-Qualified Retirement Savings Plan.